Medicare Enrolled

Dr. Amarie Negron-Rodriguez

Rheumatology · Fort Lauderdale, FL
Practice pattern: Mixed Practice — Diverse clinical practice across multiple procedure types
Low-engagement
2900 W CYPRESS CREEK RD, Fort Lauderdale, FL 33309
9542297030
In practice since 2007 (18 years)
NPI: 1326240565 verify on NPPES ↗
Very High
DATA COVERAGE
Data in 4 of 4 federal sources
Measures public federal data availability — not provider quality
Informational, not a quality rating. This page presents federal public records about Dr. Negron-Rodriguez from CMS (NPPES, Open Payments, Medicare Provider Utilization, PECOS). It is not medical advice, an endorsement, or a judgment of clinical quality. Always consult the provider directly and a licensed clinician for medical decisions. Read methodology →
Are you Dr. Negron-Rodriguez? Request a correction or review of any data shown here. Provider portal →

What this data tells you about Dr. Negron-Rodriguez

Dr. Amarie Negron-Rodriguez is a rheumatology specialist in Fort Lauderdale, FL, with 18 years of NPI registration. Based on federal Medicare data, Dr. Negron-Rodriguez performed 19,520 Medicare services across 298 unique beneficiaries.

Between the years covered by Open Payments, Dr. Negron-Rodriguez received a total of $12,617 from 38 pharmaceutical and/or device companies across 428 individual payments. These payments are legal, publicly disclosed under the federal Sunshine Act, and common in rheumatology. Most payments are for meals and travel — low-value interactions common across virtually all practicing physicians. Patients may wish to discuss these relationships with their provider.

The Data Coverage level for Dr. Negron-Rodriguez is Very High — reflecting how much public federal data is available about this provider. This is not a quality rating. Patients are encouraged to use this data as one of several factors when choosing a healthcare provider.

✓ 18 years in practice ▲ Top 44% volume in FL $12,617 industry payments

Medicare Practice Summary

Medicare Utilization ↗
19,520
Medicare services
Top 44% in FL for rheumatology
298
Unique beneficiaries
$14
Avg. Medicare payment
Medicare patients only (65+ / disabled) · Not a quality rating · How to read this →
~1,084 Medicare services per year of practice

Top procedures by volume

Ranked by number of services performed for Medicare patients. Avg. submitted charge is what the provider billed; avg. Medicare payment is what CMS paid.

Procedure Volume Avg. paid Avg. submitted
Certolizumab injection (Cimzia) 14,000 $4 $11
Abatacept infusion (Orencia) 4,925 $34 $86
Office visit, established patient (30-39 min) 261 $99 $270
Office visit, established patient (20-29 min) 101 $61 $184
Administration of chemotherapy into vein, 1 hour or less 96 $103 $345
Administration of non-hormonal anti-neoplastic chemotherapy under skin or into muscle 83 $58 $189
New patient office visit (45-59 min) 30 $127 $415
Injection, methylprednisolone acetate, 80 mg 24 $9 $40
How to read this data: This reflects Medicare patients only (typically 65+). Payment amounts are what Medicare paid the provider, not your out-of-pocket cost. A higher procedure volume generally indicates more experience with that procedure.
25.2% high complexity
72.8% medium
2.0% routine

Industry Payment Transparency

Open Payments through 2024 ↗
$12,617
Total received (2018-2024)
Avg $1,802/year across 7 years
Top 37% in FL for rheumatology
38
Companies
428
Individual payments
All payments are legal and publicly reported · Not evidence of wrongdoing · How to interpret →

Payment profile

Industry payments classified by relationship type. Not all payments are equal — research and consulting reflect different relationships than speaking programs or meals.

Meals & Travel
Food, beverages, travel, and lodging — typically low-value
$10,415 (82.5%)
Speaking / Promotional
Speaker programs, honoraria, and industry-sponsored educational events
$994 (7.9%)
Consulting
Expert advisory fees, typically reflecting recognized clinical expertise
$800 (6.3%)
Scientific / Research
Research funding and grants
$408 (3.2%)

Payment trend by year

Annual totals from pharmaceutical and medical device companies.

2024
$2,838
2023
$2,147
2022
$1,384
2021
$1,809
2020
$1,666
2019
$1,239
2018
$1,535

Payments by company (2024)

Consulting
Speaking
Meals & Travel
Research
ABBVIE INC.
$2,119
Amgen Inc.
$1,606
Janssen Biotech, Inc.
$1,112
GlaxoSmithKline, LLC.
$1,086
UCB, Inc.
$652
Lilly USA, LLC
$634
E.R. Squibb & Sons, L.L.C.
$631
PFIZER INC.
$585
AstraZeneca Pharmaceuticals LP
$432
AbbVie, Inc.
$363
Novartis Pharmaceuticals Corporation
$350
Radius Health, Inc.
$321
AbbVie Inc.
$297
Genentech USA, Inc.
$284
GENZYME CORPORATION
$224
Aurinia Pharma U.S., Inc.
$194
Horizon Therapeutics plc
$193
Mallinckrodt Hospital Products Inc.
$159
SOBI, INC
$136
Mallinckrodt LLC
$126
SANOFI-AVENTIS U.S. LLC
$124
Alexion Pharmaceuticals, Inc.
$122
Boehringer Ingelheim Pharmaceuticals, Inc.
$106
Mallinckrodt Enterprises LLC
$96
Alvogen Inc
$95
Actelion Pharmaceuticals US, Inc.
$66
Celgene Corporation
$65
Fresenius Kabi USA, LLC
$63
ANI Pharmaceuticals, Inc.
$61
Octapharma USA, Inc.
$54
Kiniksa Pharmaceuticals International, plc
$54
Ultragenyx Pharmaceutical Inc.
$42
Antares Pharma, Inc.
$39
Sobi, Inc
$34
Nevro Corp.
$33
MERZ NORTH AMERICA, INC.
$22
MEDEXUS PHARMA, INC.
$17
Spinal Simplicity, LLC
$17
Top 3 companies account for 38.3% of total payments
Associated products mentioned in payments ›
ACTHAR · Actemra · Arcalyst · BENLYSTA · Bimzelx · COSENTYX · Cimzia · Crysvita · EVENITY · Enbrel · FORTEO · HA MINUTEMAN G3-R · HUMIRA · Humira · IDACIO · KEVZARA · KINERET · KRYSTEXXA · Kineret · LUPKYNIS · OCTAGAM IMMUNE GLOBULIN (HUMAN) · OFEV · ORENCIA · Otezla · PENNSAID · PURIFIED CORTROPHIN GEL · Prolia · REMICADE · RINVOQ · Rasuvo · Rinvoq · Rituxan · SAPHNELO · SILTEX Breast Implants · SIMPONI ARIA · SKYRIZI · STELARA · STRENSIQ · Senza · TALTZ · TAVNEOS · TERIPARATIDE · TREMFYA · Tavneos · Tymlos · XELJANZ · XYOSTED
Should you be concerned? Payments from pharmaceutical and device companies are legal and common — 57% of U.S. physicians receive at least one. They often reflect legitimate consulting, research, or education. What matters is whether a recommended drug or device appears in your doctor's payment records. If so, consider asking your doctor about it. How to interpret this data →

Most payments (82%) are for meals and travel — low-value interactions that are common across virtually all practicing physicians.

Equivalent to $65 per 100 Medicare services performed
Looking for a rheumatology specialist in Fort Lauderdale?
Compare rheumatologists in the Fort Lauderdale area by procedure volume, costs, and industry payment transparency.
Browse rheumatologists nearby

Geographic Context

Rheumatologists within 10 mi
84
Per 100K population
4.3
County median income
$74,534
Nearest hospital
FORT LAUDERDALE BEHAVIORAL HEALTH CENTER
2.4 mi

Data Sources

Provider Registry ✓ NPPES Weekly updates
Medicare Enrollment ✓ PECOS Monthly updates
Practice Data ✓ Medicare Util. Annual (CY lag)
Industry Payments ✓ Open Payments CY 2024
Disciplinary History — Not public N/A

This provider has data in 4 of 4 available federal datasets, with a Data Coverage level of Very High. This measures how much public data is available about a provider — not how good they are. How we calculate this →

Summary

Dr. Negron-Rodriguez is a mixed practice specialist, with moderate Medicare volume, with low-engagement industry engagement, with 18 years of NPI registration.

This summary is auto-generated from federal data. It describes data availability and patterns — not clinical quality. Read our methodology →

Frequently Asked Questions

Is Dr. Negron-Rodriguez experienced with certolizumab injection (cimzia)?
Based on Medicare claims data, Dr. Negron-Rodriguez performed 14,000 certolizumab injection (cimzia) services. Research suggests that higher procedure volume is often associated with better outcomes, particularly for complex procedures. Note that Medicare data only captures patients aged 65 and older, so the total practice volume across all patients is likely higher.
Does Dr. Negron-Rodriguez receive payments from pharmaceutical companies?
Yes. Dr. Negron-Rodriguez received a total of $12,617 from 38 companies across 428 individual payments. These payments are legal, publicly disclosed under the federal Sunshine Act, and common among physicians — 57% of all U.S. physicians receive at least one industry payment. Patients may wish to ask their doctor about these relationships, especially if a recommended drug or device appears in the payment records.
How do Dr. Negron-Rodriguez's costs compare to other rheumatologists in Fort Lauderdale?
Dr. Negron-Rodriguez's average Medicare payment per service is $14. Note that these figures represent what Medicare pays, not your out-of-pocket cost, which depends on your specific insurance plan and deductible. Procedure-level data above shows both what was submitted and what Medicare paid for each service type.
What does Data Coverage mean?
Data Coverage (currently Very High for Dr. Negron-Rodriguez) measures how much public federal data is available about a provider. It is not a quality rating. A "Very High" or "High" level means the provider has data across multiple federal sources (NPPES, PECOS, Medicare Utilization, Open Payments), indicating a long track record of practice, Medicare participation, and industry disclosure. A "Low" or "Moderate" level may simply mean the provider is newer, does not see Medicare patients, or has not received any industry payments — none of which are inherently negative. Read our full methodology →
Is this data up to date?
Each data source has its own update cycle. Provider registry data (NPPES) is updated weekly. Medicare enrollment (PECOS) is updated monthly. Medicare practice data has a ~2 year lag — the most recent available is typically 2 years prior. Industry payment data (Open Payments) is published annually, usually in June, covering the prior calendar year. We display the data date prominently on each section so you always know how current it is. See our data freshness policy →

Explore related providers

Same specialty & city
Rheumatologists in Fort Lauderdale
Browse rheumatologists in Fort Lauderdale ranked by procedure volume and transparency data.
Highest volume
Top Rheumatologists in FL
Rheumatologists ranked by total Medicare services performed statewide.
Industry payments
Pharma Payments to Rheumatologists in FL
Which FL rheumatologists receive the most from drug and device companies.
By company
ABBVIE INC. Payments to Doctors
See all physicians who received payments from ABBVIE INC.
By company
Amgen Inc. Payments to Doctors
See all physicians who received payments from Amgen Inc.
By company
Janssen Biotech, Inc. Payments to Doctors
See all physicians who received payments from Janssen Biotech, Inc.
About this page

All data on this page is sourced verbatim from public federal records published by the U.S. Centers for Medicare & Medicaid Services (CMS): NPPES ↗, Open Payments ↗, Medicare Provider Utilization ↗, and PECOS. Publication is mandated by the Physician Payments Sunshine Act (§6002 ACA, 42 U.S.C. §1320a-7h) and the Freedom of Information Act.

This page is not medical advice, an endorsement, a recommendation, or a quality rating. The Transparency Score measures data completeness — how much federal information exists for this provider — not clinical performance, patient outcomes, or quality of care. Always verify information directly with the provider and consult a licensed clinician before making medical decisions.

Provider corrections: Provider portal · Privacy questions: Privacy Policy · Terms: Terms of Use · Methodology: Methodology

Data Disclaimer — Data sourced from the Centers for Medicare & Medicaid Services (CMS): National Plan and Provider Enumeration System (NPPES), Open Payments program, Medicare Provider Utilization and Payment Data, and Provider Enrollment & Certification data (PECOS). Published under the Freedom of Information Act (FOIA). This website is not affiliated with, endorsed by, or authorized by CMS, HHS, or the U.S. Government. Data may contain errors as reported to CMS by providers and reporting entities. Payments from industry are legal and do not indicate wrongdoing. Medicare data reflects only patients aged 65+ or those with qualifying disabilities. For corrections, contact CMS directly. This information does not constitute medical advice and should not be used as the sole basis for choosing a healthcare provider. Procedure descriptions use plain language and do not reference CPT® codes, which are copyrighted by the American Medical Association. Full methodology → · Report a data error → · Privacy policy →